Study of Magrolimab Combination Therapy in Patients With Non-Surgically Removable Locally Advanced or Metastatic Triple-Negative Breast Cancer

PHASE2TerminatedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

December 14, 2021

Primary Completion Date

October 8, 2024

Study Completion Date

October 8, 2024

Conditions
Triple-Negative Breast Cancer
Interventions
DRUG

Magrolimab

Administered intravenously

DRUG

Nab-Paclitaxel

Administered intravenously

DRUG

Paclitaxel

Administered intravenously

DRUG

Sacituzumab Govitecan-hziy

Administered intravenously

Trial Locations (45)

131

Chang Gung Memorial Hospital, Linkou, Guishan District

3065

St Vincent's Hospital Melbourne, Fitzroy

3128

Box Hill Hospital, Box Hill

3199

Peninsula Health, Frankston

3355

Ballarat Oncology & Haematology Services, Wendouree

4102

Princess Alexandra Hospital, Woolloongabba

4556

University of the Sunshine Coast, Sippy Downs

4870

Cairns and Hinterland Hospital and Health Service, Cairns

5000

Cancer Research SA, Adelaide

5042

Flinders Medical Centre, Bedford Park

5505

Asan Medical Center, Seoul

10016

NYU Investigational Pharmacy, Laura & Isaac Perlmutter Cancer Center, New York

10408

National Cancer Center, Goyang-si

11257

Taipei Veterans General Hospital, Beitou District

11794

Stony Brook University, Stony Brook

29414

Charleston Oncology, Charleston

30265

Southeastern Regional Medical Center, LLC, Newnan

30322

Winship Cancer Institute Emory University, Atlanta

30607

University Cancer & Blood Center,LLC, Athens

32224

Mayo Clinic, Jacksonville

50006

Changhua Christian Hospital, Changhua

55407

Allina Health Cancer Institute, Minneapolis

55905

Mayo Clinic, Rochester

60077

Orchard Healthcare Research Inc, Skokie

70121

Ochsner Clinic Foundation, New Orleans

80778

Kaohsiung Medical University Chung-Ho Memorial Hospital, Sanmin District

84112

Huntsman Cancer Institute, University of Utah, Salt Lake City

85054

Mayo Clinic, Phoenix

90404

Saint John's Cancer Institute, Santa Monica

92835

Providence Medical Foundation, Fullerton

93710

Women's Cancer Care, Fresno

94115

University of California San Francisco, San Francisco

95403

Providence Medical Foundation, Santa Rosa

08816

Astera Cancer Care, East Brunswick

'03220

Barwon Health- University Hospital Geelong, Geelong

Unknown

Queen Mary Hospital, Hong Kong

Princess Margaret Hospital, Kowloon

Prince of Wales Hospital, New Territories

National Taiwan University Hospital, Tapiei

06351

Samsung Medical Center, Gangnam-Gu

110-744

Seoul National University Hospital, Jongrogu

03722

Severance Hospital Yonsei University Health System, Seoul

LE1 5WW

University Hospitals of Leicester NHS Trust, Leicester

WC1E 6BT

University College London, London

M20 4BX

The Christie NHS Foundation Trust, Manchester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Gilead Sciences

INDUSTRY